付表ⅣA 完成品である薬品の製造に用いられるその他の産品

1 (Sub-heading) 1,1'-(4- ) (4- )1,1'-(4-Chlorobutylidene)bis(4-fluorobe nzene) m- m-Chlorobenzyl 4- -1- -1- Sodium 4-chloro-1-hydroxy-1-butane 2- -1,3- 2-Phenyl-1, 4- -3- 2- -6- 3- -2,5- 3-Chloropropyl-2,5-xylyl 3- -4- - 1 Monosodium salt of { 4-(2- ) }-Oxirane{[4-(2-methoxyethyl)phenoxy}met hyl] 1,1- -2-(2- ) 1,1-Dimethoxy-2-(2-methoxyethoxy) 2- 2-Nitrobenzaldehyde Dimethyl 9,10- -9(10H)- 9,10-Ethanoanthracene-9(10H) 6- -2- 10,11- -5H- - a,d - -5- 10,11-Dihydro-5H-dibenzo-[a,d] 5-H- - a,d - -5- 5-H-Dibenzo-[a,d] Isobutyl -1,4- -3,20- ,11,17,21- -16- -,(11.)

2 ,16..)-Pregna-1,4-diene-3,20-dione,11,17 ,21-trihydroxy-16-methyl-,(11. alpha., ) 9- ,11- - 17- ,21- -16- - -1,4- -3,20- (9,11- )9-beta,11-beta-Epoxy 17-alpha,21-dihydroxy-16-beta-methylpreg na-1,4-diene-3,20-dione (9,11-epoxide) 2- -1(2,4- ) 2-Chloro-1(2,4-dichlorophenyl) 4-(3,4- )1- 4-(3,4 Dichlorophenyl) 4- -1-(4- )-1- 4-Chloro-1-(4-fluorophenyl) 4- -1- 4-(1,1- ) -1- 4-Chloro-1-[4-(1,1-dimethylethyl)phenyl] 16- - -1,4- -17- ,21- -3,20- ,21- 16-alpha-Methyl-1,4-pregnadiene-17-alpha ,21-diol-3,20-dione,21 21- -17- - -16- - -1,4,9- -3,20- 21-Acetoxy-17-alpha-hydroxy-16-beta-meth ylpregna-1,4,9-triene- 3, 21- -17- - -16- - -1,4- -3,20- 21-Acetoxy-17-alpha-hydroxy-16-beta-meth ylpregna-1,4-diene-3,20- 2- -4- -1- 2- -4- -1- -9,11- -16- delta-9, 2- -4,5- 2-Chloro-4.

3 5-difluorobenzoic -(2- )- - alpha-(2-Bromoethyl) -4- Mono-4-nitrobenzyl malonate magnesium Monophenyl phenyl Calcium lactate D- D-Mandelic Acid IVA 1 10 (Sub-heading) 1,2,6,7,8,8- - , - -2 ,6 - -8 -(2 - -1- )-1 - 1,2,6,7,8,8-alpha-Hexahydro beta beta, deltabeta-dihydroxy-2 beta,6 alpha-dimethyl-8 alpha-(2beta-methyl-1-oxobutoxy)-1 beta-naphthaleneheptanoic acid, ammonium 8(S)-(2,2- -1- )-1,2,6,7,8,8- (R), - (R), (R)- -2(S),6(R)- -1(S)- 8(S)-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7, 8,8-alpha(R), hexahydro-beta(R),delta(R)-dihydroxy-2(S ),6(R)-dimethyl-1(S)- naphthaleneheptanoicacid, ammonium D(-) - - - D(-)

4 Alpha-Formyloxy-alpha-phenylacetyl -(R)-(-)-3- Methyl-(R)-(-) 3-(2- -4,5- )-3- 3-(2-Chloro-4,5-difluorophenyl)-3-oxopro pionicacid ethyl -2- -4- (6- ,11- ,16- ,17- )-6,9- -11,17- -16- -3- -1,4- -17- (6-alpha,11-beta,16-alpha,17-alpha)-6,9- Difluoro-11,17-dihydroxy-16-methyl-3-oxo androsta-1,4-diene-17-carboxylic 4-( ) 4-(Phenylbutoxy) benzoic -3,4- Isobutyl-3, Diethyl ethoxymethylene 5- -2- Methyl 5-glyoxylyl-2-hydroxybenzoate (1- ) Phosphorofluoridic acid bis (1-methylethyl) 5- -2,4- 5-Chloroaniline-2,4-disulfonyl 1- ,4-(3,4- )-1,2,3,4- -N- - , -( )-1-Naphthaleneamine,4-(3,4-dichlorophen yl)-1,2,3,4-tetrahydro-N- methyl-hydrochloride,trans-(.)

5 +-.) N- N- N-Methylprotriptyline ', ', '- -2,3- alpha',alpha',alpha'-Trifluoro-2, (1S,2R)-1- -3- -2- -1- -1- (1S,2R) (2S,3R)-(+)-4- -3- -1,2- -2- (2S,3R)-(+)-4-Dimethylamino-3-methyl-1, 1- -1-( )-D- 1-Deoxy-1-(octylamino) 2-(3,4- ) 2-(3,4-Dimethoxyphenyl) 2- -2'- -5- 2-Amino-2' - -4-(2- )-(S)-, L- 1:1 Benzeneacetic acid, alpha-methyl-4-(2methylpropyl)-(S)-, compound with L-lysine (1.

6 1) (S,S)-H-(1-( -3- - ) (S,S)-H-(1-(Carboethoxy-3-phenyl-propyl) 2- 3- -, 2-Butenoic acid,3-amino-,methyl 4- 4-Amino butyric D(-)- - D(-) D(-)- - (3- -1- -3- -1- )- Potassium D(-)-alpha-[(3-methoxy-1-methyl-3-oxo-1- propenyl)-amino]phenyl Dihydro phenyl D(-)- - (3- -1- -3- -1- )- - Sodium D(-)-alpha-[(3-methoxy-1-methyl-3-oxo-1- propenyl)-amino]- phenyl (2S,3R)-(+)-2-(1S)- -3- -1,5- - -5- (2S,3R)-(+)-2-(1S)-Hydroxyethyl-3-amino- 1,5-pentane-dioic acid-5 methyl 2-(N- -N- )-4'- -3'- 2-(N-Benzyl-N-tert-butylamino)-4'-hydrox y-3'-hydroxymethylacetophenone hydrochloride2 10 (Sub-heading) 3' -2'- 3' Amino-2'-hydroxyacetophenone 4- -5- -2- 4-Amino-5-chloro-2-methoxybenzoic 4- - -1- { 6-(4- ) - } -1,3- 4-Hydroxy-alpha-1-[{[6-(4-phenylbutoxy)) ]]}

7 Hexyl]-amino}methyl]-1,3- D(-)-4- D(-)-4-Hydroxyphenyl d(-)-4- - d(-)-4-Hydroxyphenyl N- -N- -2- -2-(3'- -4'- ) N-Benzyl-N-tert-butyl-2-hydroxy-2-(3'-hy droxymethyl-4'-hydroxyphenyl) -2-(2- -4,5- - )-3-(2,4- - )-2- Ethyl-2-(2-chloro-4,5-difluoro-benzoyl)- 3-(2,4-difluoro phenyl-amino) D(-)- - (3- -1- -3- -1- )- -4- Potassium D(-)-alpha[(3-methoxy-1-methyl-3-oxo-1-p ropenyl)-amino]-4-hydroxy phenyl D(-)- - (3- -1- -3- -1- )- -4- Sodium D(-)-alpha-[(3-methoxy-1-methyl-3-oxo-1- propenyl)-amino]- 4-hydroxyphenyl - -3,4- - Benzene-ethanamine-3, 3-{( ) }-1,2,3,9- -9- -4H- -4- 3-{(Dimethylamino)methyl}-1,2,3,9-tetrah ydro-9-methyl-4H- 1- ,2- ( ) -N,N,N- -, 1-Propanaminium,2-[(aminocarbonyl)oxy]-N ,N,N-trimethyl-, L- 1 L-Asparagine N-(2- ) N-(2-Hydroxyethyl)

8 N,O- -(S)- N,0-Diformyl-(S) 2,2- 2, 2- 4-(2- -3- ) 2-[4-(2-Hydroxy-3-isopropylaminopropoxy) phenyl] 2- -N- 3-( ) 2-Methyl-N-[3-(trifluoromethyl)phenyl] 3- -4-( ) -2- 3-[-4-(phenylbutoxy) benzoylamino] 4- -N- 5-(N,N- ) 5-(N,N-Dibenzylglycyl) 5- -2- 5-Glyoxyl-2-hydroxybenzamide N-( )-DL- N-(Benzyl oxycarbonyl) N- N-Acetylsulfanilyl 3- -4- -6- - Methyl 2,6- 4-(4- )2,6-Piperidinedione 4-(4-chlorophenyl) (1)-N-( - -4- -3- - ) (1)-N-(alpha-Cyano-4-hydroxy-3-methoxy-a lphamethylphenethyl) 1,1'- -2- ,4'- [1,1'-Biphenyl]-2-carbonitrile, 4' 1-(4- )-4- - 1-(4-Fluorophenyl) 2-(3- ) 2-(3-Phenoxyphenyl) 3,4,5- 3,4, 3- -N-(1,1- )

9 - -3,5- -17 - 3-Cyana-N-(1,1-dimethylethyl)-androsta-3 ,5-diene-17 - -3,4,5- alpha-Isopropyl-3,4,5-trimethoxybenzyl - -3,4- alpha-Isopropyl-3,4-dimethoxy Ethyl ethoxymethylene 2-( )-2- 2-(Aminooxy)-2-methylpropanoic acid,monohydrochloride3 10 (Sub-heading) N- - -N- - - 2- D-(-)-3- -2- D-(-)-3 Acetylthio-2-methyl propanoic D-()